...
首页> 外文期刊>Tissue engineering, Part A >Expansion and delivery of adipose-derived mesenchymal stem cells on three microcarriers for soft tissue regeneration.
【24h】

Expansion and delivery of adipose-derived mesenchymal stem cells on three microcarriers for soft tissue regeneration.

机译:在三个微载体上扩增和递送脂肪衍生的间充质干细胞,用于软组织再生。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Cell/microcarrier combinations can be injected to repair tissue defects, but whether currently available microcarriers can be utilized to repair different tissue defects remains unknown. Here, we compared the suitability of fabricated micronized acellular dermal matrix (MADM), micronized small intestinal submucosa (MSIS), and gelatin microspheres as expansion and delivery scaffolds for adipose-derived mesenchymal stem cells (ADSCs). The results of MTS assay, scanning electron microscopy (SEM), and flow cytometry suggested that the three microcarriers all have good biocompatibility. Quantitative polymerase chain reaction revealed enhanced epidermal growth factor, vascular endothelial growth factor, basal fibroblast growth factor, and transforming growth factor-beta expression levels after ADSCs had been cultured on MADM or MSIS for 5 days. After culturing ADSCs on microcarriers in osteogenic medium for 7 days, the expression levels of bone formation-related genes were enhanced. ADSC/microcarrier treatment accelerated wound closure. The ADSC/MADM and ADSC/MSIS combinations retained more of the original implant volume at 1 month postimplantation than ADSC/gelatin microspheres combination in soft-tissue augmentation studies. All implants displayed fibroblast and capillary vessel infiltrations; but ectopic bone formation did not occur, and the calvarial defect repair results were unfavorable. Our study demonstrates the potential utility of these microcarriers not only as a cell-culture substrate but also as a cell-transplantation vehicle for skin regeneration and soft-tissue reconstruction.
机译:可以注射细胞/微载体组合以修复组织缺陷,但是目前可用的微载体是否可用于修复不同的组织缺陷仍然未知。在此,我们将制造的微粉化无细胞皮质基质(MADM),微粉化小肠粘膜下颌(MSIS)和明胶微球的适用性与脂肪衍生的间充质干细胞(ADSCs)进行了膨胀和递送支架。 MTS测定的结果,扫描电子显微镜(SEM)和流式细胞术表明,三种微载体均具有良好的生物相容性。定量聚合酶链反应显示出增强的表皮生长因子,血管内皮生长因子,基础成纤维细胞生长因子,并在对MADM或MSIS培养5天的ADSC或MSIs后转化生长因子-β表达水平。在骨载体上培养骨质载体的患者7天后,提高了骨形成相关基因的表达水平。 ADSC /微载体处理加速伤口闭合。 ADSC / MADM和ADSC / MSIS组合在1个月的后期后保留了更多的原始植入物体积,而不是软组织增强研究中的ADSC / Gelatin微球组合。所有植入物显示成纤维细胞和毛细血管血管渗透;但没有发生异位骨形成,并且颅骨缺陷修复结果是不利的。我们的研究表明这些微载体的潜在效用不仅是细胞培养基质,而且作为用于皮肤再生和软组织重建的细胞 - 移植载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号